Related Experiment Video
Updated: Jan 4, 2026
06:45
Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
Published on: February 10, 2023
15.6K
[Antithrombotic therapy in lower extremity arterial disease]
Michele Franzese1, Enrico Coscioni2, Martina Scalise1
1Dipartimento di Scienze Biomediche Avanzate, A.O.U. "Federico II", Napoli.
Giornale Italiano Di Cardiologia (2006)
|November 8, 2019
Summary
Antithrombotic therapy is crucial for patients with lower extremity arterial disease (LEAD) to prevent cardiovascular events. Recent evidence supports the use of antiplatelets and anticoagulants in LEAD management, addressing historical underprescription.
Area of Science:
- Vascular Medicine
- Cardiology
- Pharmacology
Background:
- Lower extremity arterial disease (LEAD) impacts over 200 million globally, causing significant morbidity and disability.
- Current treatment often involves inadequate antithrombotic agent prescription, despite recommendations for cardiovascular event prevention.
Purpose of the Study:
- To review and summarize existing scientific evidence supporting antithrombotic agent use in patients with LEAD.
- To address the historical underutilization of antithrombotic therapies in this patient population.
Main Methods:
- Systematic review of recent clinical trials and scientific literature.
- Analysis of data on antiplatelet and anticoagulant efficacy in LEAD patients.
Main Results:
- Recent clinical trial data increasingly support the efficacy of antithrombotic drugs in managing LEAD.
- Evidence indicates that appropriate antithrombotic therapy can reduce adverse cardiovascular events in LEAD patients.
Conclusions:
- Antithrombotic therapy, including antiplatelets and anticoagulants, is supported by current evidence for patients with LEAD.
- Improved prescription of these agents is warranted to optimize outcomes and reduce complications in lower extremity arterial disease.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
247
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
247
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
01:27Peripheral Artery Disease III: Interprofessional Care
210
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
210
01:30Venous Thrombosis IV: Nursing Management
169
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
169
01:23Peripheral Artery Disease V: Postoperative Nursing Management
329
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
329
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.0K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.0K